HOLX
May 1, 2023 - AI Summary
Undervalued by 29.2% based on the discounted cash flow analysis.
Market cap | $17.77 Billion |
---|---|
Enterprise Value | $18.42 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $2.09 |
Beta | 0.0 |
Outstanding Shares | 234,731,521 |
Avg 30 Day Volume | 1,542,098 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 34.5 |
---|---|
PEG | 109.4 |
Price to Sales | 4.74 |
Price to Book Ratio | 3.99 |
Enterprise Value to Revenue | 4.64 |
Enterprise Value to EBIT | 20.37 |
Enterprise Value to Net Income | 35 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.55 |
No data
No data
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.